Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study.
The Lancet. Haematology
View this publicationThe Lancet. Haematology
View this publicationJournal of cardiovascular computed tomography
View this publicationPharmaceutics
View this publicationThe New England journal of medicine
View this publicationMovement disorders : official journal of the Movement Disorder Society
View this publicationJHEP reports : innovation in hepatology
View this publicationScientific reports
View this publicationBMC infectious diseases
View this publicationEuropean urology
View this publicationInternational journal of molecular sciences
View this publication